Norway· NO-ID_A1A80BBA-4125-4098-9BA2-1D5D6DCB1745
Botox
A botulinus toxin product containing botulinum toxin + type a + purified neurotoxin component, registered in Norway by AbbVie AS. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Botulinus toxin is registered in 11 of 19 countries.
Countries holding a registration under ATC M03AX01 (botulinus toxin), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Botulinus toxin · ATC M03AX01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Botulinum Toxin + Type A + Purified Neurotoxin Component
- Manufacturer
- AbbVie AS
- Country
- Norway (NO)
- ATC code
- M03AX01
- ATC class
- Botulinus Toxin
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 7
3 priced- no_merkevare_idID_A1A80BBA-4125-4098-9BA2-1D5D6DCB1745
- no_varenummer1778093 x 200NOK 13643.5
- no_varenummer095092200NOK 4572
- no_varenummer12865910 x 200NOK 45393.9
- gtin8054083027708
- gtin5016007203240
- gtin8054083027715
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for botulinus toxin.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Botulinus toxin · interactions on record
55 records
- 11 severe
- 44 moderate
Most severe, free to view
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- KanamycinA07AA08severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under M03AX01
Botulinus toxin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc86ffcd-100b-4c2d-874d-73a27d57f260 GET /v1/drugs/bc86ffcd-100b-4c2d-874d-73a27d57f260?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Botulinumtoksin",
"merkevare_id": "ID_A1A80BBA-4125-4098-9BA2-1D5D6DCB1745",
"name_form_strength": "Botox pulv til inj væske, oppl 200 E",
"prescription_group": "C"
}See everything about botulinus toxin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.